The author regrets that in Table 1 of this manuscript, the suggested dose for hypofractionated radiotherapy was erroneously described as 55 Gy/10 fractions for tumours of up to 10cm in length. In keeping with the main text of the article, which is correct, this should have described a recommended dose of 50-55 Gy/20 fractions.
. 2021 Mar 29;33(8):e362. doi: 10.1016/j.clon.2021.03.010
Corrigendum to “Considerations for the Treatment of Oesophageal Cancer with Radiotherapy During the COVID-19 Pandemic” [Clin Oncol 32 (2020) 354–357]
CM Jones
∗,†,‡, M Hawkins
§, S Mukherjee
¶, G Radhakrishna
||, T Crosby
∗∗,∗
CM Jones
∗School of Molecular & Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK
†Radiotherapy Research Group, Leeds Institute of Medical Research at St James's, Faculty of Medicine & Health, University of Leeds, Leeds, UK
‡Leeds Cancer Centre, The Leeds Teaching Hospitals NHS Trust, Leeds, UK
Find articles by CM Jones
M Hawkins
§Department of Medical Physics & Biomedical Engineering, University College London, London, UK
Find articles by M Hawkins
S Mukherjee
¶CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK
Find articles by S Mukherjee
G Radhakrishna
||Christie Hospital, The Christie NHS Foundation Trust, Manchester, UK
Find articles by G Radhakrishna
∗School of Molecular & Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK
†Radiotherapy Research Group, Leeds Institute of Medical Research at St James's, Faculty of Medicine & Health, University of Leeds, Leeds, UK
‡Leeds Cancer Centre, The Leeds Teaching Hospitals NHS Trust, Leeds, UK
§Department of Medical Physics & Biomedical Engineering, University College London, London, UK
¶CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK
||Christie Hospital, The Christie NHS Foundation Trust, Manchester, UK
∗∗Velindre Cancer Centre, Cardiff, UK
∗
Author for correspondence: T. Crosby, Velindre Cancer Centre, Velindre Road, Whitchurch, Cardiff CF14 2TL, UK. Tel: +44-29-2061-5888.
Issue date 2021 Aug.
© 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8436418 PMID: 33795184
This corrects the article "Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic" in volume 32 on page 354.